Parag Kumar
Impact in
- Immunology top 5%
- Immunodeficiency and Autoimmune Disorders
- interferon and immune responses
- Infectious Diseases top 10%
Papers in
-
- HIV/AIDS drug development and treatment 5
-
- Immunodeficiency and Autoimmune Disorders 3
- Co-authors
- Kristina M. Brooks (12 shared papers)Ashwini Mallappa (4 shared papers)William C. Zamboni (6 shared papers)Deborah P. Merke (4 shared papers)Ninet Sinaii (3 shared papers)Jomy M. George (7 shared papers)Kevin Laliberte (3 shared papers)Ashkan A. Malayeri (1 shared paper)
- Journals
- The Journal of Clinical Pharmacology (5 papers)Clinical Pharmacology & Therapeutics (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)Clinical Infectious Diseases (2 papers)The Journal of Clinical Endocrinology & Metabolism (2 papers)
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
Parag Kumar
43 papers receiving 2k citations
Parag Kumar's Hit Papers
Peers
Comparison fields: 5 of 106
- Immunology 442
- Infectious Diseases 254
- Biomaterials 140
- Endocrinology, Diabetes and Metabolism 151
- Pharmacology 76
Countries citing papers authored by Parag Kumar
This map shows the geographic impact of Parag Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Parag Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Parag Kumar more than expected).
Fields of papers citing papers by Parag Kumar
This network shows the impact of papers produced by Parag Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Parag Kumar. The network helps show where Parag Kumar may publish in the future.
Co-authors
The 25 scholars most cited alongside Parag Kumar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies Hit paper breakdown → | 2018 | 417 |
| 2 | 2019 | 150 | |
| 3 | 2019 | 140 | |
| 4 | 2014 | 129 | |
| 5 | 2018 | 123 | |
| 6 | 2017 | 105 | |
| 7 | 2018 | 98 | |
| 8 | 2016 | 96 | |
| 9 | 2016 | 68 | |
| 10 | 2013 | 67 | |
| 11 | 2016 | 61 | |
| 12 | 2012 | 60 | |
| 13 | 2017 | 55 | |
| 14 | 2014 | 51 | |
| 15 | 2018 | 49 | |
| 16 | 2017 | 48 | |
| 17 | 2018 | 32 | |
| 18 | 2015 | 27 | |
| 19 | 2015 | 25 | |
| 20 | 2016 | 21 |
About Parag Kumar
Parag Kumar is a scholar working on Infectious Diseases, Immunology, Pharmacology, Biomaterials and Endocrinology, Diabetes and Metabolism, having authored 44 papers that have together received 2k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (6 papers), Pharmacogenetics and Drug Metabolism (6 papers), HIV/AIDS drug development and treatment (5 papers), Adrenal Hormones and Disorders (5 papers), Sexual Differentiation and Disorders (4 papers), Pulmonary Hypertension Research and Treatments (3 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). The work is most often cited by research in Immunology (442 citations), Infectious Diseases (254 citations), Biomaterials (140 citations), Endocrinology, Diabetes and Metabolism (151 citations) and Pharmacology (76 citations). Parag Kumar has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Kristina M. Brooks, Ashwini Mallappa, William C. Zamboni, Deborah P. Merke, Ninet Sinaii, Jomy M. George, Kevin Laliberte, Ashkan A. Malayeri, David A. Bluemke and Daniel S. Reich. Their work appears in journals such as The Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics, Cancer Chemotherapy and Pharmacology, Clinical Infectious Diseases and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.